Please assess the completion status of the following clinical trial:

Trial Title: A 21 Day Irritation Study in Healthy Volunteers With Diacerein 1% Ointment

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Key Inclusion Criteria:~* Is a healthy male or female (to be confirmed by medical history);~* Is 18 years of age or older;~* In the case of a female of childbearing potential, is using two acceptable forms of birth control;~* In the case of a female of childbearing potential, has a negative urine pregnancy test (UPT) on Day 1 prior to randomization and are willing to submit to a UPT at the end of study (EOS);~* Is free of any systemic or dermatological disorder, which, in the opinion of the Investigator, will interfere with the study results or increase the risk of AEs;~* Is of any Fitzpatrick Skin Type or race, providing the skin pigmentation will allow discernment of erythema~Key Exclusion Criteria:~* Has any visible skin disease at the application site which, in the opinion of the Investigator, will interfere with the evaluation of the test site reaction;~* Is using systemic/topical corticosteroids within 3 weeks prior to and/or during the study, or systemic/topical antihistamines 72 hours prior to and during the study;~* Is not willing to refrain from using systemic/topical anti-inflammatory analgesics such as aspirin, (occasional use of acetaminophen will be permitted);~* Is using medication which, in the opinion of the Investigator, will interfere with the study results;~* Is unwilling or unable to refrain from the use of sunscreens, cosmetics, creams, ointments, lotions or similar products on the back during the study;~* Has psoriasis and/or active atopic dermatitis/eczema;~* Has a known sensitivity or allergy to constituents of the materials being evaluated including diacerein, mineral oil, petrolatum, cetyl alcohol, D\&C Yellow #10 and/or ethyl paraben;~* Has damaged skin in or around the test sites, including sunburn, excessively deep tans, uneven skin tones, tattoos, scars, excessive hair, numerous freckles, or other disfigurations of the test site;~* Has received treatment for any type of internal cancer within 5 years prior to study entry;~* Has any known sensitivity to adhesives; and/or~* Has received any investigational drug(s) within 4 weeks prior to study entry

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- study in healthy volunteers (Type: OTHER): diacerein 1% ointment

Based on this trial design, predict the completion outcome and termination type (if applicable).